Authors:
MOHAN R
YUN WY
BUCKMAN BO
LIANG A
TRINH L
MORRISSEY MM
Citation: R. Mohan et al., SOLID-PHASE SYNTHESIS OF N-SUBSTITUTED AMIDINOPHENOXY PYRIDINES AS FACTOR XA INHIBITORS, Bioorganic & medicinal chemistry letters, 8(14), 1998, pp. 1877-1882
Citation: Kk. Cho et al., SYSTEM-ANALYSIS OF A MULTIPRODUCT, SMALL-LOT-SIZED PRODUCTION BY SIMULATION - A KOREAN MOTOR FACTORY CASE, Computers & industrial engineering, 30(3), 1996, pp. 347-356
Citation: Dl. Boger et al., (- AND ENT-(-)-DUOCARMYCIN SA AND (+)- AND ENT-(-)-N-BOC-DSA DNA ALKYLATION PROPERTIES - ALKYLATION SITE MODELS THAT ACCOMMODATE THE OFFSETAT-RICH ADENINE N3 ALKYLATION SELECTIVITY OF THE ENANTIOMERIC AGENTS()), Journal of the American Chemical Society, 116(5), 1994, pp. 1635-1656
Citation: Dl. Boger et Wy. Yun, CBI-TMI - SYNTHESIS AND EVALUATION OF A KEY ANALOG OF THE DUOCARMYCINS - VALIDATION OF A DIRECT RELATIONSHIP BETWEEN CHEMICAL SOLVOLYTIC STABILITY AND CYTOTOXIC POTENCY AND CONFIRMATION OF THE STRUCTURAL FEATURES RESPONSIBLE FOR THE DISTINGUISHING BEHAVIOR OF ENANTIOMERIC PAIRS OF AGENTS, Journal of the American Chemical Society, 116(18), 1994, pp. 7996-8006
Citation: Dl. Boger et Wy. Yun, ROLE OF THE CC-1065 AND DUOCARMYCIN N-2 SUBSTITUENT - VALIDATION OF ADIRECT RELATIONSHIP BETWEEN SOLVOLYSIS CHEMICAL-STABILITY AND IN-VITRO BIOLOGICAL POTENCY, Journal of the American Chemical Society, 116(12), 1994, pp. 5523-5524
Citation: Dl. Boger et Wy. Yun, REVERSIBILITY OF THE DUOCARMYCIN-A AND SA DNA ALKYLATION REACTION, Journal of the American Chemical Society, 115(21), 1993, pp. 9872-9873